We are live on ! Find out more

2,018 hedge funds and large institutions have $120B invested in Merck in 2018 Q2 according to their latest regulatory filings, with 120 funds opening new positions, 780 increasing their positions, 868 reducing their positions, and 77 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 120 | Existing positions closed: 77

37% more funds holding in top 10

Funds holding in top 10: 84115 (+31)

10% more call options, than puts

Call options by funds: $1.22B | Put options by funds: $1.1B

10% more capital invested

Capital invested by funds: $110B → $120B (+$10.7B)

1% more funds holding

Funds holding: 1,9932,018 (+25)

0.83% less ownership

Funds ownership: 78.21%77.38% (-0.83%)

10% less repeat investments, than reductions

Existing positions increased: 780 | Existing positions reduced: 868

Holders
2,018
Holders Change
+25
Holders Change %
+1.25%
% of All Funds
46.19%
Holding in Top 10
115
Holding in Top 10 Change
+31
Holding in Top 10 Change %
+36.9%
% of All Funds
2.63%
New
120
Increased
780
Reduced
868
Closed
77
Calls
$1.22B
Puts
$1.1B
Net Calls
+$112M
Net Calls Change
-$116M
Name Holding Trade Value Shares
Change
Change in
Stake
NFG
1376
Nations Financial Group
Iowa
$775K -$68.2K -1,209 -8%
FPS
1377
Fieldpoint Private Securities
Connecticut
$773K +$56 +1 +0%
HAIM
1378
Hunter Associates Investment Management
Pennsylvania
$770K
OAM
1379
Occidental Asset Management
California
$769K -$62.6K -1,109 -8%
BEC
1380
Blue Edge Capital
Virginia
$768K
HT
1381
Heritage Trust
Oklahoma
$767K +$17.4K +309 +2%
ANTB
1382
AMG National Trust Bank
Colorado
$767K +$747K +13,235 New
FWP
1383
FAS Wealth Partners
Kansas
$765K +$3.44K +61 +0.5%
GC
1384
Grimes & Company
Massachusetts
$764K -$2M -35,421 -73%
BG
1385
Bellevue Group
Switzerland
$759K
BI
1386
Boulegeris Investments
Georgia
$759K +$113K +1,996 +18%
AF
1387
Aldebaran Financial
$755K +$564 +10 +0.1%
SCA
1388
Sage Capital Advisors
South Dakota
$755K +$89.5K +1,587 +14%
MPAM
1389
Murphy Pohlad Asset Management
Minnesota
$752K -$17.5K -310 -2%
MCM
1390
Marathon Capital Management
Maryland
$747K -$1.47K -26 -0.2%
MBT
1391
Montecito Bank & Trust
California
$743K -$21.6K -382 -3%
CWM
1392
Calamos Wealth Management
Illinois
$742K -$15.6K -277 -2%
TIA
1393
Tiemann Investment Advisors
California
$738K
Westfield Capital Management
1394
Westfield Capital Management
Massachusetts
$738K
DBRC
1395
D.B. Root & Company
Pennsylvania
$736K +$5.36K +95 +0.8%
NA
1396
Navellier & Associates
Nevada
$735K -$65K -1,152 -8%
LMAM
1397
Legg Mason Asset Management
Japan
$735K -$23.6K -419 -3%
NPT
1398
Nixon Peabody Trust
Massachusetts
$730K +$15.2K +269 +2%
1WA
1399
180 Wealth Advisors
Washington
$730K +$430K +7,615 +153%
BRC
1400
Bell Rock Capital
Delaware
$729K -$48.8K -865 -6%

MRK Hedge Fund Activity: Q2 2018 in Review

2,018 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2018, worth a combined $120B — up 9.7% from $110B a quarter earlier.

Buyers outnumbered sellers: 120 funds opened new MRK positions and 77 closed out — a net gain of 43 holders — while 780 added to existing stakes and 868 trimmed.

The largest buyer was Capital World Investors, adding an estimated $904M. The largest seller was Dodge & Cox, cutting an estimated $620M.

  • 2,018 institutional investors held Merck (MRK) as of Q2 2018, up from 1,993 in Q1 2018.
  • Funds reported $120B of Merck stock for Q2 2018, up 9.7% quarter-over-quarter.
  • 120 funds opened new Merck positions in Q2 2018 and 77 closed out, a net change of +43 holders.
  • The largest Merck buyer in Q2 2018 was Capital World Investors, an estimated $904M added.
  • The largest Merck seller in Q2 2018 was Dodge & Cox, an estimated $620M sold.

Based on aggregated 13F filings for Q2 2018.